PI3K Inhibition for Squamous Cell Head and Neck Carcinoma

被引：5
|
作者：
Desilets, Antoine [1 ,2 ]
Soulieres, Denis [1 ]
机构：
[1] Ctr Hosp Univ Montreal CHUM, Pavillon C,1000 Rue St Denis, Montreal, PQ H2X 0C1, Canada
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
CANCER JOURNAL | 2022年 / 28卷 / 05期
关键词：
Head and neck squamous cell carcinoma; PI3K inhibitors; targeted therapy; PHOSPHOINOSITIDE 3-KINASE INHIBITOR; I DOSE-ESCALATION; BUPARLISIB BKM120; PACLITAXEL; RECURRENT; CHEMOTHERAPY; COMBINATION; EXPRESSION; RECEPTOR; NIVOLUMAB;
D O I：
10.1097/PPO.0000000000000618
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The phosphoinositide 3-kinase (PI3K) pathway is aberrantly activated in most head and neck squamous cell carcinomas, making it a prized target for targeted therapy development. Multiple PI3K inhibitors have been studied in early phase trials, with unfavorable risk-benefit ratios in molecularly unselected patient populations. Buparlisib, a potent pan-class I PI3K inhibitor, shows promising efficacy in combination with paclitaxel for advanced head and neck squamous cell carcinoma. Results of the phase III BURAN trial are awaited.
引用
收藏
页码：369 / 376
页数：8
相关论文
共 50 条
  • [21] Evaluation of co-inhibition of ErbB family kinases and PI3K for HPV-negative head and neck squamous cell carcinoma
    Geng, Xinyan
    Azarbarzin, Shirin
    Yang, Zejia
    Lapidus, Rena G.
    Fan, Xiaoxuan
    Teng, Yong
    Mehra, Ranee
    Cullen, Kevin J.
    Dan, Hancai
    ONCOLOGY REPORTS, 2025, 53 (03)
  • [22] Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition
    Ruicci, Kara M.
    Plantinga, Paul
    Pinto, Nicole
    Khan, Mohammed I.
    Stecho, William
    Dhaliwal, Sandeep S.
    Yoo, John
    Fung, Kevin
    MacNeil, Danielle
    Mymryk, Joe S.
    Barrett, John W.
    Howlett, Christopher J.
    Nichols, Anthony C.
    MOLECULAR ONCOLOGY, 2019, 13 (10) : 2160 - 2177
  • [23] TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinoma
    Ruicci, Kara M.
    Meens, Jalna
    Plantinga, Paul
    Stecho, William
    Pinto, Nicole
    Yoo, John
    Fung, Kevin
    MacNeil, Danielle
    Mymryk, Joe S.
    Barrett, John W.
    Howlett, Christopher J.
    Boutros, Paul C.
    Ailles, Laurie
    Nichols, Anthony C.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
  • [24] Nanog promotes PI3K/Akt and mTOR-mediated invasion in head and neck squamous cell carcinoma
    Rahimy, Elham
    Yi, David
    Lew, Daniel
    Abhold, Eric
    Kiang, Alan
    Wang-Rodriguez, Jessica
    Ongkeko, Weg
    CANCER RESEARCH, 2012, 72
  • [25] Assessment of phosphatidylinositol-3 kinase (PI3K) as a prognostic marker in head and neck squamous cell carcinoma (HNSCC)
    Pectasides, E.
    Founztilas, G.
    Sasaki, C.
    Burtness, B.
    Psyrri, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [26] Targeted Inhibition of PI3K and MEK in Combination With Radiation Therapy in UT15: A Murine Model of Head and Neck Squamous Cell Carcinoma
    Blas, K. G., Jr.
    Galoforo, S.
    Wilson, T. G.
    Krueger, S. A.
    Grills, I. S.
    Marples, B.
    Wilson, G. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E578 - E579
  • [27] CDK 4/6 Inhibition Overcomes Acquired and Inherent Resistance to PI3Kα Inhibition in Pre-Clinical Models of Head and Neck Squamous Cell Carcinoma
    Remer, Eric
    Badarni, Mai
    Hikri, Elad
    Dayan, Avraham
    Levi, Lirit
    Popovtzer, Aron
    Iraqi, Muhammed
    Porgador, Angel
    Joshua, Ben-Zion
    Bachar, Gideon
    Elkabets, Moshe
    Scaltriti, Maurizio
    Mizrachi, Aviram
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (10) : 1 - 12
  • [28] MAPK and PI3K signalling differentially regulate angiogenic and lymphangiogenic cytokine secretion in squamous cell carcinoma of the head and neck
    Luangdilok, Sutima
    Box, Carol
    Harrington, Kevin
    Rhys-Evans, Peter
    Eccles, Suzanne
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (04) : 520 - 529
  • [29] Radiation Enhancement of Head and Neck Squamous Cell Carcinoma by the Dual PI3K/mTOR Inhibitor PF-05212384
    Leiker, Andrew J.
    DeGraff, William
    Choudhuri, Rajani
    Sowers, Anastasia L.
    Thetford, Angela
    Cook, John A.
    Van Waes, Carter
    Mitchell, James B.
    CLINICAL CANCER RESEARCH, 2015, 21 (12) : 2792 - 2801
  • [30] EGFR/PI3K/AKT/MTOR PATHWAY IN HEAD AND NECK SQUAMOUS CELL CARCINOMA PATIENTS WITH DIFFERENT HPV STATUS
    Janecka-Widla, Anna
    Majchrzyk, Kaja
    Mucha-Malecka, Anna
    Biesaga, Beata
    POLISH JOURNAL OF PATHOLOGY, 2021, 72 (04) : 296 - 314
12345